The nurse is caring for a client who has heart failure and a history of asthma. The nurse reviews the provider's orders and recognizes that clarification is needed for which of the following medications?

Rationale: A. An ACE inhibitor used in heart failure, captopril reduces afterload, decreases blood pressure, and improves cardiac output. It is safe for clients with asthma because it does not cause bronchoconstriction. Nurses should monitor for side effects like cough or hyperkalemia, but respiratory status is typically not affected. B. A non-selective beta-blocker, carvedilol blocks both beta-1 and beta-2 receptors, which can trigger bronchospasm in clients with asthma or reactive airway disease. In these patients, a cardioselective beta-blocker (e.g., metoprolol or atenolol) is preferred to reduce the risk of respiratory compromise. Clarification is needed to ensure safe management of heart failure without exacerbating asthma. C. This nitrate reduces preload through venous dilation, helping relieve heart failure symptoms. It is generally safe for clients with asthma because it does not affect bronchial smooth muscle. Nurses should monitor for headache, hypotension, and dizziness as common side effects. D. An inhaled corticosteroid indicated for asthma management, fluticasone reduces airway inflammation and prevents asthma exacerbations. It is safe to use in clients with heart failure and does not interact adversely with cardiac medications.